 | • レポートコード：360iR22NB041 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、249ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の調査レポートでは、世界のコレステロール検査市場規模が2021年の159.4億ドルから、2022年に173.8億ドルに達すると予測しています。今後、2027年まで年平均9.29%で、27.17億ドルまでに成長する見込みです。本市場調査資料では、コレステロール検査の世界市場を調査対象とし、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品種類別（コレステロール検査キット、コレステロール検査ストリップ）分析、検査別（高密度リポタンパク質（HDL）コレステロール、低密度リポタンパク質（LDL）、トータルコレステロール検査）分析、検査種類別（侵襲的、非侵襲的）分析、処方別（店頭、処方箋ベース）分析、エンドユーザー別（外来センター、診療所、診断センター、在宅医療、病院）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などを整理しました。本書ではBio-Reference Laboratories, Inc.、Cell Biolabs, Inc.、Clinical Reference Laboratory, Inc.、Eurofins Scientific、F. Hoffmann-La Roche Ltd.、Quest Diagnostics Incorporated、Randox Laboratories Ltd.、Spectra Laboratories, Inc.、Synlab International GmbH、Thermo Fisher Scientific Inc.などの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のコレステロール検査市場規模：製品種類別 - コレステロール検査キットの市場規模 - コレステロール検査ストリップの市場規模 ・世界のコレステロール検査市場規模：検査別 - 高密度リポタンパク質（HDL）コレステロール検査の市場規模 - 低密度リポタンパク質（LDL）コレステロール検査の市場規模 - トータルコレステロール検査の市場規模 ・世界のコレステロール検査市場規模：検査種類別 - 侵襲的コレステロール検査の市場規模 - 非侵襲的コレステロール検査の市場規模 ・世界のコレステロール検査市場規模：処方別 - 店頭入手可能コレステロール検査の市場規模 - 処方箋ベースコレステロール検査の市場規模 ・世界のコレステロール検査市場規模：エンドユーザー別 - 外来センターにおける市場規模 - 診療所における市場規模 - 診断センターにおける市場規模 - 在宅医療における市場規模 - 病院における市場規模 ・世界のコレステロール検査市場規模：地域別 - 南北アメリカのコレステロール検査市場規模 アメリカのコレステロール検査市場規模 カナダのコレステロール検査市場規模 ブラジルのコレステロール検査市場規模 ... - アジア太平洋のコレステロール検査市場規模 日本のコレステロール検査市場規模 中国のコレステロール検査市場規模 インドのコレステロール検査市場規模 韓国のコレステロール検査市場規模 台湾のコレステロール検査市場規模 ... - ヨーロッパ/中東/アフリカのコレステロール検査市場規模 イギリスのコレステロール検査市場規模 ドイツのコレステロール検査市場規模 フランスのコレステロール検査市場規模 ロシアのコレステロール検査市場規模 ... - その他地域のコレステロール検査市場規模 ・競争状況 ・企業情報 |
The Global Cholesterol Testing Market size was estimated at USD 15.94 billion in 2021 and expected to reach USD 17.38 billion in 2022, and is projected to grow at a CAGR 9.29% to reach USD 27.17 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Cholesterol Testing to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product Type, the market was studied across Test Kits and Testing Strips.
Based on Test, the market was studied across High-density Lipoprotein (HDL) Cholesterol, Low-density Lipoprotein (LDL), and Total Cholesterol Test.
Based on Test Type, the market was studied across Invasive and Non-invasive.
Based on Prescription Mode, the market was studied across Over the Counter and Prescription-based.
Based on End-users, the market was studied across Ambulatory Centers, Clinics, Diagnostic Centers, Homecare, and Hospitals.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Cholesterol Testing market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cholesterol Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cholesterol Testing Market, including Bio-Reference Laboratories, Inc., Cell Biolabs, Inc., Clinical Reference Laboratory, Inc., Eurofins Scientific, F. Hoffmann-La Roche Ltd., Quest Diagnostics Incorporated, Randox Laboratories Ltd., Spectra Laboratories, Inc., Synlab International GmbH, and Thermo Fisher Scientific Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Cholesterol Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cholesterol Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cholesterol Testing Market?
4. What is the competitive strategic window for opportunities in the Global Cholesterol Testing Market?
5. What are the technology trends and regulatory frameworks in the Global Cholesterol Testing Market?
6. What is the market share of the leading vendors in the Global Cholesterol Testing Market?
7. What modes and strategic moves are considered suitable for entering the Global Cholesterol Testing Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of cardiovascular diseases worldwide
5.1.1.2. Proliferation in number of obese people attributed to changing eating habits
5.1.1.3. Surge in the geriatric population
5.1.2. Restraints
5.1.2.1. Availability and preference over self-testing and preference for non-invasive cholesterol tests
5.1.3. Opportunities
5.1.3.1. Favorable government and private organization campaigns to undergo regular cholesterol checkups
5.1.3.2. Robust investment in healthcare and technological advancements
5.1.4. Challenges
5.1.4.1. Strict regulatory policies in testing
5.2. Cumulative Impact of COVID-19
6. Cholesterol Testing Market, by Product Type
6.1. Introduction
6.2. Test Kits
6.3. Testing Strips
7. Cholesterol Testing Market, by Test
7.1. Introduction
7.2. High-density Lipoprotein (HDL) Cholesterol
7.3. Low-density Lipoprotein (LDL)
7.4. Total Cholesterol Test
8. Cholesterol Testing Market, by Test Type
8.1. Introduction
8.2. Invasive
8.3. Non-invasive
9. Cholesterol Testing Market, by Prescription Mode
9.1. Introduction
9.2. Over the Counter
9.3. Prescription-based
10. Cholesterol Testing Market, by End-users
10.1. Introduction
10.2. Ambulatory Centers
10.3. Clinics
10.4. Diagnostic Centers
10.5. Homecare
10.6. Hospitals
11. Americas Cholesterol Testing Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Cholesterol Testing Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Cholesterol Testing Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. Bio-Reference Laboratories, Inc.
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. Cell Biolabs, Inc.
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. Clinical Reference Laboratory, Inc.
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Eurofins Scientific
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. F. Hoffmann-La Roche Ltd.
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Quest Diagnostics Incorporated
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. Randox Laboratories Ltd.
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. Spectra Laboratories, Inc.
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. Synlab International GmbH
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Thermo Fisher Scientific Inc.
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing